Header cover image
  • Investing Ideas
  • Indian Pharmaceuticals & Biotech Undervalued based on future growth

Indian Pharmaceuticals & Biotech Undervalued based on future growth

Results

1

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

1 companies

Strides Pharma Science

Market Cap: ₹89.2b

A pharmaceutical company, engages in the development, manufacturing, and marketing of pharmaceutical products in North America, Australia, Africa, Europe, India, the rest of Asia, and internationally.

STAR

₹967.80

7D

-3.6%

1Y

8.1%